Ashland, Inc.

  • Market Cap: Small Cap
  • Industry: FMCG
  • ISIN: US0441861046
USD
58.29
0.01 (0.02%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Ashland, Inc. stock-summary
stock-summary
Ashland, Inc.
FMCG
Ashland Global Holdings Inc. is a global specialty chemicals company. The Company operates through two segments: Specialty Ingredients, and Intermediates and Solvents. The Specialty Ingredients provides cellulose ethers, vinyl pyrrolidones and biofunctionals for consumer and industrial applications, including personal care, pharmaceutical, health and wellness, food and beverage, coatings and energy. In addition, it offers chemical technologies in gelcoats, coatings, and intermediates and solvents. The Intermediates and Solvents division is a producer of 1,4 butanediol and its derivatives, including tetrahydrofuran and n-methylpyrrolidone. The Company serves customers in a wide range of consumer and industrial markets, including adhesives, architectural coatings, automotive, construction, energy, food and beverage and personal care.
Company Coordinates stock-summary
Company Details
8145 BLAZER DRIVE , WILMINGTON DE : 19808
stock-summary
Tel: 1 304 9953000
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 91 Schemes (58.42%)

Foreign Institutions

Held by 142 Foreign Institutions (10.64%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Guillermo Novo
Chairman of the Board, Chief Executive Officer
Dr. Jay Ihlenfeld
Lead Independent Director
Mr. Brendan Cummins
Independent Director
Mr. William Dempsey
Independent Director
Ms. Susan Main
Independent Director
Mr. Jerome Peribere
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
463 Million
(Quarterly Results - Jun 2025)
Net Profit:
-719 Million
stock-summary
Industry

FMCG

stock-summary
Market cap

USD 2,495 Million (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

85.52%

stock-summary
Debt Equity

0.60

stock-summary
Return on Equity

-6.57%

stock-summary
Price to Book

1.32